nach oben

PharmacoEconomics

Erschienen in:

01.02.2010 | Consensus Statement

Principles of Design of Access with Evidence Development Approaches

A Consensus Statement from the Banff Summit

verfasst von: Devidas Menon, Christopher J. McCabe, Tania Stafinski, Richard Edlin

Erschienen in: PharmacoEconomics | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Excerpt

Healthcare payers are increasingly entering into innovative reimbursement agreements to manage the tension between funding new but expensive treatments, and obtaining value (measured in terms of clinical effectiveness, improved quality of care, health-related quality of life [HR-QOL], etc.) for money. These often commit substantial resources, and thus impose a significant opportunity cost on healthcare systems. Commentators and stakeholders are increasingly concerned that not all such approaches represent good value for money.[1,2] However, there is little if any literature providing guidance on their design or evaluation. …

Sudlow CLM, Counsell CE. Problems with the UK governments risk sharing scheme for assessing drugs for multiple sclerosis. BMJ 2003; 326: 388–92PubMedCrossRef

Wright M. Getting bang for buck from patient access schemes. PJ Online 2009 Nov 4 [online]. Available from URL: (http://www.pjonline.com/news/getting_bang_for_buck_from_patient_access_schemes) [Accessed 2009 Nov 30]

Stafinski T, McCabe CJ, Menon D. Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems. Pharmacoeconomics 2010; 28 (2): 113–42PubMedCrossRef

McCabe CJ, Stafinski T, Edlin R, et al. Access with evidence development schemes: a framework for description and evaluation. Pharmacoeconomics 2010; 28 (2): 143–52PubMedCrossRef

Briggs A, Ritchie K, Fenwick E, et al. Access with evidence development in the UK: past experience, current initiatives and future potential. Pharmacoeconomics 2010; 28 (2): 163–70PubMedCrossRef

Mohr PE, Tunis SR. Access with evidence development: the US experience. Pharmacoeconomics 2010; 28 (2): 153–62PubMedCrossRef

Titel: Principles of Design of Access with Evidence Development Approaches
A Consensus Statement from the Banff Summit
verfasst von: Devidas Menon
Christopher J. McCabe
Tania Stafinski
Richard Edlin
Publikationsdatum: 01.02.2010
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 2/2010
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.2165/11530860-000000000-00000

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Principles of Design of Access with Evidence Development Approaches

A Consensus Statement from the Banff Summit

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

Funding the Unfundable

Can’t Get No Satisfaction? Will Pay for Performance Help?

Access with Evidence Development in the UK

We Know Accurately Only When We Know Little

Access with Evidence Development Schemes

Access with Evidence Development